Treating hyperopia with laser in situ keratomileusis
LI Li, Z. TAO, 高如尧, 卢佩勇, 蒙艳春
Abstract
LI Li, Z. TAO, 高如尧, 卢佩勇, 蒙艳春
Abstract
目的 评价准分子激光原位角膜磨镶术(LASIK)治疗的效果和安全性.方法对16例(30眼)远视行LASIK.术前远视度数为+3.50~+12.5D,平均(+7.09±2.62)D.术后随访观察12月.结果术中无严重并发症,术后3月屈光度基本稳定,术后12月残余屈光度在+1.00D和+2.00D以内的分别占40.00%(12眼)和63.33%(19眼),裸眼近视力≥0.5者30眼(100.00%),≥1.0者24眼(80.00%),裸眼远视力≥0.5者26眼(86.67%),≥1.0者9眼(30.00%),1眼(3.33%)最佳矫正视力下降一行,5眼(16.67%)有眩光.结论 LASIK治疗远视安全有效.治疗软件进一步完善及治疗参数进一步的调整将有助于提高手术的可预测性和稳定性。
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
目的 评价准分子激光原位角膜磨镶术(LASIK)治疗的效果和安全性.方法对16例(30眼)远视行LASIK.术前远视度数为+3.50~+12.5D,平均(+7.09±2.62)D.术后随访观察12月.结果术中无严重并发症,术后3月屈光度基本稳定,术后12月残余屈光度在+1.00D和+2.00D以内的分别占40.00%(12眼)和63.33%(19眼),裸眼近视力≥0.5者30眼(100.00%),≥1.0者24眼(80.00%),裸眼远视力≥0.5者26眼(86.67%),≥1.0者9眼(30.00%),1眼(3.33%)最佳矫正视力下降一行,5眼(16.67%)有眩光.结论 LASIK治疗远视安全有效.治疗软件进一步完善及治疗参数进一步的调整将有助于提高手术的可预测性和稳定性。
Key concepts: Keratomileusis, Medicine, Ophthalmology, In situ, Chemistry, Cornea, Organic chemistry